Germany · Delayed Price · Currency is EUR ETR:MED Statistics
Total Valuation
ETR:MED has a market cap or net worth of EUR 163.40 million. The enterprise value is 472.56 million.
| Market Cap | 163.40M |
| Enterprise Value | 472.56M |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
ETR:MED has 47.50 million shares outstanding.
| Current Share Class | 47.50M |
| Shares Outstanding | 47.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 36.34% |
| Float | 11.44M |
Valuation Ratios
The trailing PE ratio is 6.41 and the forward PE ratio is 4.47.
| PE Ratio | 6.41 |
| Forward PE | 4.47 |
| PS Ratio | 0.20 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | 3.03 |
| P/OCF Ratio | 1.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.20, with an EV/FCF ratio of 8.75.
| EV / Earnings | 18.54 |
| EV / Sales | 0.59 |
| EV / EBITDA | 4.20 |
| EV / EBIT | 7.84 |
| EV / FCF | 8.75 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 1.57.
| Current Ratio | 1.68 |
| Quick Ratio | 1.50 |
| Debt / Equity | 1.57 |
| Debt / EBITDA | 3.47 |
| Debt / FCF | 7.24 |
| Interest Coverage | 2.89 |
Financial Efficiency
Return on equity (ROE) is 10.97% and return on invested capital (ROIC) is 7.79%.
| Return on Equity (ROE) | 10.97% |
| Return on Assets (ROA) | 4.31% |
| Return on Invested Capital (ROIC) | 7.79% |
| Return on Capital Employed (ROCE) | 8.96% |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | 114,872 |
| Profits Per Employee | 3,654 |
| Employee Count | 6,974 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 96.49 |
Taxes
In the past 12 months, ETR:MED has paid 9.30 million in taxes.
| Income Tax | 9.30M |
| Effective Tax Rate | 26.41% |
Stock Price Statistics
The stock price has increased by +16.22% in the last 52 weeks. The beta is 0.41, so ETR:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +16.22% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 3.42 |
| Relative Strength Index (RSI) | 46.23 |
| Average Volume (20 Days) | 13,821 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:MED had revenue of EUR 801.12 million and earned 25.49 million in profits. Earnings per share was 0.54.
| Revenue | 801.12M |
| Gross Profit | 168.26M |
| Operating Income | 60.18M |
| Pretax Income | 35.20M |
| Net Income | 25.49M |
| EBITDA | 82.52M |
| EBIT | 60.18M |
| Earnings Per Share (EPS) | 0.54 |
Balance Sheet
The company has 82.36 million in cash and 390.83 million in debt, with a net cash position of -308.48 million or -6.49 per share.
| Cash & Cash Equivalents | 82.36M |
| Total Debt | 390.83M |
| Net Cash | -308.48M |
| Net Cash Per Share | -6.49 |
| Equity (Book Value) | 249.63M |
| Book Value Per Share | 5.24 |
| Working Capital | 114.77M |
Cash Flow
In the last 12 months, operating cash flow was 102.44 million and capital expenditures -48.43 million, giving a free cash flow of 54.01 million.
| Operating Cash Flow | 102.44M |
| Capital Expenditures | -48.43M |
| Depreciation & Amortization | 22.34M |
| Net Borrowing | -77.11M |
| Free Cash Flow | 54.01M |
| FCF Per Share | 1.14 |
Margins
Gross margin is 21.00%, with operating and profit margins of 7.51% and 3.18%.
| Gross Margin | 21.00% |
| Operating Margin | 7.51% |
| Pretax Margin | 4.39% |
| Profit Margin | 3.18% |
| EBITDA Margin | 10.30% |
| EBIT Margin | 7.51% |
| FCF Margin | 6.74% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.45% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.16% |
| Earnings Yield | 15.60% |
| FCF Yield | 33.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:MED has an Altman Z-Score of 1.62 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 7 |